So this month should see Journey medical corp report full year results in the USA
They if course have Qbrexa, our potential competition for patients. That said IF APPROVED SB should be superior.
Will be interesting to see annual sales, although note Japan was only approved Feb 22.
DYOR. GLTAH
- Forums
- ASX - By Stock
- BOT
- Ann: Half Yearly Report and Accounts
Ann: Half Yearly Report and Accounts, page-42
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
(20min delay)
|
|||||
Last
42.0¢ |
Change
-0.005(1.18%) |
Mkt cap ! $761.8M |
Open | High | Low | Value | Volume |
43.0¢ | 44.5¢ | 41.5¢ | $2.435M | 5.697M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
20 | 819538 | 41.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
42.0¢ | 29052 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
17 | 812389 | 0.415 |
12 | 882907 | 0.410 |
12 | 652220 | 0.405 |
22 | 618050 | 0.400 |
7 | 263887 | 0.395 |
Price($) | Vol. | No. |
---|---|---|
0.425 | 19000 | 2 |
0.430 | 1700 | 1 |
0.435 | 280334 | 3 |
0.440 | 756891 | 12 |
0.445 | 202539 | 8 |
Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online